Accropeutics has developed a robust pipeline focusing on inflammation, fibrosis, autoimmune diseases and cancer
asset | rights | indication | Discovery | Pre-Clinical | IND | Phase I | Phase II |
---|---|---|---|---|---|---|---|
AC-003 Learn more |
![]() |
IPF |
|
||||
![]() |
GVHD |
|
|||||
![]() |
Rheumatoid Arthritis |
|
|||||
![]() |
Ulcerative Colitis |
|
|||||
AC-101 Learn more |
![]() |
IBD |
|
||||
![]() |
Anti-inflammation |
|
|||||
AC-201 Learn more |
![]() |
Psoriasis |
|
||||
![]() |
SLE |
|
|||||
AC-203 |
![]() |
Rheumatoid Arthritis |
|
||||
![]() |
AS, HS, AD, AA, SLE |
|
|||||
AC-301 |
![]() |
DLBCL |
|
||||
![]() |
Leukemia |
|
|||||
![]() |
Anti-inflammation |
|